FDA Adverse Event Injury Summary report: N

CM ALVIM IMPLANT 3.5X13

MDR report key: 8681244 · Received June 8, 2019

Report

Report Number
3008261720-2019-02565
Event Type
Injury
Date Received
June 8, 2019
Date of Event
March 13, 2019
Report Date
July 12, 2019
Manufacturer
NEODENT - JJGC S.A.
Product Code
DZE
UDI-DI
07898237568737
PMA / PMN Number
K101945
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UT, US
Reporter Occupation
DENTIST

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL PATIENT CODE(S) (F10): 1994/PAIN; 2091/SWELLING; 1932/INFLAMMATION; 1888/BLEEDING. ADDITIONAL EVALUATION C. CONCLUSION: 19/CAUSE TRACED TO USER THE COMPLAINT WAS RECEIVED BY MANUFACTURER AND, AFTER ANALYSIS, NEW INFORMATIONS WERE OBTAINED. A FOLLOW-UP IS BEING SENT TO CORRECT THESE INFORMATIONS ACCORDING TO THE EVALUATION MADE. THE INVESTIGATION OF THE COMPLAINT WAS CARRIED OUT CONSIDERING THE ANALYSIS OF THE INFORMATION GIVEN BY THE DENTIST IN THE GUARANTEE FORM, VISUAL CONFERENCE OF THE PRODUCT RETURNED BY THE DENTIST AND THE EVALUATION OF RELEVANT PRODUCTION RECORDS.

Additional Manufacturer Narrative · 0

ADDITIONAL PATIENT CODE(S) (F10): 1994/PAIN; 2091/SWELLING; 1932/INFLAMMATION; 1888/BLEEDING. EXEMPTION NUMBER: E2015015. INSTRADENT USA, INC IS SUBMITTING THE REPORT ON BEHALF OF NEODENT - JJGC. THE INFORMATION PROVIDED IN THIS REPORT WAS BASED ON INFORMATION GIVENBY THE DENTIST IN NEODENT¿S PRODUCTS WARRANTY FORM THAT WAS RECORDED IN THE SYSTEM THAT IS USED BY BOTH THE MANUFACTURER AND THE SUBSIDIARY. THE ORIGINAL COMPLAINT AND THE PRODUCT WERE RECEIVED BY THE SUBSIDIARY AND DID NOT ARRIVE IN THE MANUFACTURER YET. WHEN THIS HAPPENS, A NEW EVALUATION OF THE COMPLAINT WILL BE CARRIED OUT AND, IF NECESSARY, A NEW FOLLOW-UP REPORT WILL BE SEND.

Additional Manufacturer Narrative · 0

ADDITIONAL PATIENT CODE(S) (F10): 1994/PAIN; 2091/SWELLING; 2104/TISSUE DAMAGE. EXEMPTION NUMBER: E2015015. INSTRADENT USA, INC IS SUBMITTING THE REPORT ON BEHALF OF NEODENT - JJGC.

Description of Event or Problem · 0

THE CLINICIAN REPORTED THAT 1.5 MONTHS AFTER THE IMMEDIATE DENTAL IMPLANT WAS PLACED IN ADA SITE 26 IN THE PATIENT'S MOUTH, THE IMPLANT DID NOT ACHIEVE OSSEOINTEGRATION IN TYPE II BONE. CLINICIAN NOTED THE PATIENT'S INFECTION, PERI-IMPLANTITIS, PAIN, MOBILITY, BLEEDING, ABSCESS, INFLAMMATION AND SWELLING. THE SITE WAS GRAFTED. THE PRODUCT WILL BE FORWARDED TO THE MANUFACTURER FOR INVESTIGATION. THERE WERE NO REPORTED POST-OPERATIVE COMPLICATIONS.

Description of Event or Problem · 0

THE CLINICIAN REPORTED THAT 1.5 MONTHS AFTER THE IMMEDIATE DENTAL IMPLANT WAS PLACED IN ADA SITE 26 IN THE PATIENT'S MOUTH, THE IMPLANT DID NOT ACHIEVE OSSEOINTEGRATION IN TYPE II BONE. CLINICIAN NOTED THE PATIENT'S INFECTION, PERI-IMPLANTITIS, PAIN, MOBILITY, BLEEDING, ABSCESS, INFLAMMATION AND SWELLING. THE SITE WAS GRAFTED. THE PRODUCT WILL BE FORWARDED TO THE MANUFACTURER FOR INVESTIGATION. THERE WERE NO REPORTED POST-OPERATIVE COMPLICATIONS.

Description of Event or Problem · 0

THE CLINICIAN REPORTED THAT 1.5 MONTHS AFTER THE IMMEDIATE DENTAL IMPLANT WAS PLACED IN ADA SITE 26 IN THE PATIENT'S MOUTH, THE IMPLANT DID NOT ACHIEVE OSSEOINTEGRATION IN TYPE II BONE. CLINICIAN NOTED THE PATIENT'S INFECTION, PERI-IMPLANTITIS, PAIN, MOBILITY, BLEEDING, ABSCESS, INFLAMMATION AND SWELLING. THE SITE WAS GRAFTED. THE PRODUCT WILL BE FORWARDED TO THE MANUFACTURER FOR INVESTIGATION. THERE WERE NO REPORTED POST-OPERATIVE COMPLICATIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
474681 CM ALVIM IMPLANT 3.5X13 ENDOSSEOUS DENTAL IMPLANT DZE NEODENT - JJGC S.A. 800335818 07898237568737

Patients

Seq Age Sex Outcome Treatment
1 38 YR Required Intervention BONE GRAFT| BONE GRAFT| BONE GRAFT